Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Multicenter Trial, Examining the Effect of Miro3D Wound Matrix on the Rate of Complete Wound Closure of Chronic Diabetic Foot Ulcers

NCT07632001 is registered in ClinicalTrials.gov with Reprise Biomedical, Inc. as lead sponsor.

NCT NCT07632001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07632001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Multicenter Trial, Examining the Effect of Miro3D Wound Matrix on the Rate of Complete Wound Closure of Chronic Diabetic Foot Ulcers
Lead sponsor
Reprise Biomedical, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
June 15, 2026
Completion date
May 31, 2027
Enrollment
180 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

chronic wounds, diabetic foot, diabetic foot ulcers (dfus)